Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

CL earnings analysis

Filed May 1, 2026 · Our reading of the company's report

The latest report

Colgate-Palmolive reported Q1 2026 earnings with revenue of $5.324 billion, exceeding estimates of $5.212 billion, but EPS fell short at $0.80 against an expected $0.95. The company highlighted strong sales growth in…

Read full summary

Colgate-Palmolive reported Q1 2026 earnings with revenue of $5.324 billion, exceeding estimates of $5.212 billion, but EPS fell short at $0.80 against an expected $0.95. The company highlighted strong sales growth in Latin America and EMEA, offsetting a decline in North American sales. Full-year guidance for organic sales growth remains intact despite a revised gross margin expectation.

Read the original on SEC.gov

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $40 Operating expenses $39 Left as operating profit $21

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

Reported figures

Earnings per share
$0.8

What stood out

  • Revenue Surpassed Estimates

    Total revenue for Q1 2026 reached $5.324 billion, exceeding the estimated $5.212 billion.

  • EPS Missed Expectations

    Diluted EPS reported at $0.80, falling short of the estimated $0.95.

  • Strong Latin America Growth

    Sales in Latin America grew by 14.8%, reflecting robust demand.

  • Stable Gross Margin Percentage

    Gross margin remained stable at 60.1%, despite previous expectations of a decline.

  • Market Share Efforts

    The company continues to focus on strategic initiatives to bolster market share amid competitive pressures.

  • Increased Sales in EMEA

    EMEA segment sales rose by 11.9%, contributing to overall growth.

What to watch

  • North American Sales Decline

    Sales in North America declined by 1.8%, indicating potential weakness in this key market.

  • Strategic Initiative Costs

    Increased charges from strategic growth initiatives may impact profitability going forward.

  • Exit from Pet Food Business

    The ongoing negative impact from the strategic exit from the pet food business may affect future sales.

Management's outlook

Full-year guidance for net sales growth maintained at 2% to 6% and organic sales growth at 1% to 4%, though gross margin outlook was revised down.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.